Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Ardelyx Inc (NASDAQ: ARDX) was $3.68 for the day, up 1.52% from the previous closing price of $3.63. In other words, the price has increased by $1.52 from its previous closing price. On the day, 2.87 million shares were traded. ARDX stock price reached its highest trading level at $3.69 during the session, while it also had its lowest trading level at $3.6.
Ratios:
Our analysis of ARDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.06.
On May 02, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 16 ’25 when MOTT DAVID M bought 200,000 shares for $3.63 per share. The transaction valued at 725,880 led to the insider holds 2,896,871 shares of the business.
MOTT DAVID M bought 200,000 shares of ARDX for $737,260 on Jun 09 ’25. The Director now owns 2,696,871 shares after completing the transaction at $3.69 per share. On May 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 6,421 shares for $4.08 each. As a result, the insider received 26,207 and left with 402,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 881654720 and an Enterprise Value of 849333440. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.44 while its Price-to-Book (P/B) ratio in mrq is 6.05. Its current Enterprise Value per Revenue stands at 2.348 whereas that against EBITDA is -22.715.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.59, which has changed by -0.502699 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $8.06, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is -9.07%, while the 200-Day Moving Average is calculated to be -27.88%.
Shares Statistics:
ARDX traded an average of 5.53M shares per day over the past three months and 4158740 shares per day over the past ten days. A total of 239.20M shares are outstanding, with a floating share count of 230.69M. Insiders hold about 3.58% of the company’s shares, while institutions hold 68.86% stake in the company. Shares short for ARDX as of 1749772800 were 27283637 with a Short Ratio of 4.93, compared to 1747267200 on 27769893. Therefore, it implies a Short% of Shares Outstanding of 27283637 and a Short% of Float of 12.920000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Ardelyx Inc (ARDX) is currently being evaluated by a team of 6.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.04 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.4 and -$0.49 for the fiscal current year, implying an average EPS of -$0.44. EPS for the following year is $0.05, with 6.0 analysts recommending between $0.29 and -$0.19.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 12 analysts. It ranges from a high estimate of $87.51M to a low estimate of $72.5M. As of the current estimate, Ardelyx Inc’s year-ago sales were $73.22MFor the next quarter, 12 analysts are estimating revenue of $96.71M. There is a high estimate of $107.49M for the next quarter, whereas the lowest estimate is $84.4M.
A total of 12 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $401.46M, while the lowest revenue estimate was $344.9M, resulting in an average revenue estimate of $365.93M. In the same quarter a year ago, actual revenue was $333.62MBased on 12 analysts’ estimates, the company’s revenue will be $488.9M in the next fiscal year. The high estimate is $560.6M and the low estimate is $393.7M.
